Literature DB >> 3019827

Up-regulation of brain [3H]diazepam binding sites in chronic caffeine treated rats.

P H Wu, J W Phillis.   

Abstract

Brain [3H]diazepam and [3H]L-phenylisopropyladenosine binding sites in caffeine treated (75 mg/kg/day, i.p. 12 days) and caffeine withdrawn (30 days) rats were examined. Treatment with caffeine (75 mg/kg/day) for 12 days increases the Bmax (maximum binding capacity) for [3H]diazepam binding by 30.9% whereas the same treatment increases the Bmax for [3H]L-PIA binding by 165%. The Bmax for [3H]diazepam binding sites returns to slightly below control levels but [3H]L-PIA binding sites remain elevated after 30 days of caffeine withdrawal. These findings suggest that the up-regulation of [3H]diazepam binding sites seen in caffeine treated rats may not be adequately explained by a direct antagonism of caffeine on benzodiazepine receptors. Other modes of interaction therefore must be considered.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3019827     DOI: 10.1016/0306-3623(86)90203-x

Source DB:  PubMed          Journal:  Gen Pharmacol        ISSN: 0306-3623


  4 in total

1.  Chronic effects of xanthines on levels of central receptors in mice.

Authors:  D Shi; J W Daly
Journal:  Cell Mol Neurobiol       Date:  1999-12       Impact factor: 5.046

2.  The role of adenosine receptors in the central action of caffeine.

Authors:  John W Daly; Dan Shi; Olga Nikodijevic; Kenneth A Jacobson
Journal:  Pharmacopsychoecologia       Date:  1994

3.  Chronic caffeine alters the density of adenosine, adrenergic, cholinergic, GABA, and serotonin receptors and calcium channels in mouse brain.

Authors:  D Shi; O Nikodijević; K A Jacobson; J W Daly
Journal:  Cell Mol Neurobiol       Date:  1993-06       Impact factor: 5.046

4.  Inhibitory respiratory responses to progesterone and allopregnanolone in newborn rats chronically treated with caffeine.

Authors:  NagaPraveena Uppari; Vincent Joseph; Aida Bairam
Journal:  J Physiol       Date:  2015-12-14       Impact factor: 5.182

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.